DOTA-225-actinium

N/A

Report date: 2025/03/18 18:17:22

Base Information

Drug NameDOTA-225-actinium
Drug Alias NameN/A
ClassificationRadiation-emitting products > Radioactive therapeutic agentBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovaCurie AG
China Registration ClassN/A

Develop Information

Active CompaniesNovaCurie AG
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A